From: Preparation and in vitro evaluation of BBG-250 loaded liposomal formulation for anticancer potential
Model | GDT-HA | RMSD | MolProbity | Varify3D | Errat score | Clash score | Poor rotamers | Rama favored |
---|---|---|---|---|---|---|---|---|
Initial | 1.0000 | 0.000 | 1.187 | 54.56% | 90.7955 | 2.0 | 1.1 | 96.8 |
MODEL 1 | 0.9705 | 0.363 | 1.560 | 59.55% | 93.5943 | 11.1 | 0.0 | 98.1 |
MODEL 2 | 0.9753 | 0.357 | 1.532 | 53.82% | 88.5714 | 10.3 | 0.4 | 98.4 |
MODEL 3 | 0.9769 | 0.344 | 1.567 | 52.87% | 88.172 | 11.2 | 0.4 | 98.1 |
MODEL 4 | 0.9697 | 0.363 | 1.574 | 61.78% | 88.1533 | 11.4 | 0.4 | 98.7 |
MODEL 5 | 0.9721 | 0.378 | 1.532 | 58.60% | 87.8571 | 10.3 | 0.4 | 98.4 |